We've found
184,457
clinical trials
Endocrinology Clinical Trial
Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Dose Escalation and Expansion Study of GSK3359609 in Subjects With Selected Advanced Solid Tumors (INDUCE-1)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Reproductive Clinical Trial
Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Orthopedics / Podiatry Clinical Trial
Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures
Status: Enrolling,
Phase
IV
Updated: 1/12/2018
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
NC Young Women's CoOp
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease, Type IA Clinical Trial
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease, Type IA Clinical Trial
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease, Type IA Clinical Trial
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease, Type IA Clinical Trial
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Healthy Volunteers Clinical Trial
Effect of Transcranial Magnetic Stimulation to the Frontoparietal Attention Network on Anxiety Potentiated Startle
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
MDM2 Inhibitor AMG-232, Carfilzomib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Partners Calciphylaxis Biobank
Status: Enrolling,
Phase
Updated: 3/20/2018
Click here to add this to my saved trials
Biliary Atresia Clinical Trial
Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia
Status: Enrolling,
Phase
Updated: 3/5/2018
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Psychiatry / Psychology Clinical Trial
Effects of Sleep Restriction on BAT Activation in Humans
Status: Enrolling
Updated: 1/30/2017
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Kidney Transplantation Clinical Trial
Preventive Human Papilomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gestational Diabetes Clinical Trial
High Dose Cholecalciferol to Reduce the Incidence of Gestational Diabetes in High Risk Pregnant Women
Status: Enrolling,
Phase
I, II
Updated: 12/27/2017
Click here to add this to my saved trials
Breast Cancer, Respiratory Gating, Prone Clinical Trial
Prone Whole-Breast RadiationTherapy Versus Supine Whole-Breast Radiation Therapy Imaging
Status: Enrolling
Updated: 1/30/2017
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Vestibular Diseases Clinical Trial
Use of a Vibrotactile Balance Belt System for Vestibular Rehabilitation in the Pediatric Population
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Valve Stenosis Clinical Trial
Home-Based Exercise Program For Recovery After Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Valve Stenosis Clinical Trial
Home-Based Exercise Program For Recovery After Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Reproductive Clinical Trial
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Open-Label Extension and Safety Study of Talazoparib
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Open-Label Extension and Safety Study of Talazoparib
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Open-Label Extension and Safety Study of Talazoparib
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Open-Label Extension and Safety Study of Talazoparib
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Open-Label Extension and Safety Study of Talazoparib
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Open-Label Extension and Safety Study of Talazoparib
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Dose Escalation and Expansion Study of GSK3359609 in Subjects With Selected Advanced Solid Tumors (INDUCE-1)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Reproductive Clinical Trial
Updated: 12/31/1969
Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Orthopedics / Podiatry Clinical Trial
Updated: 1/12/2018
Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures
Status: Enrolling,
Phase
IV
Updated: 1/12/2018
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
NC Young Women's CoOp
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease, Type IA Clinical Trial
Updated: 12/31/1969
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease, Type IA Clinical Trial
Updated: 12/31/1969
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease, Type IA Clinical Trial
Updated: 12/31/1969
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease, Type IA Clinical Trial
Updated: 12/31/1969
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Healthy Volunteers Clinical Trial
Updated: 12/31/1969
Effect of Transcranial Magnetic Stimulation to the Frontoparietal Attention Network on Anxiety Potentiated Startle
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
MDM2 Inhibitor AMG-232, Carfilzomib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Updated: 3/20/2018
Partners Calciphylaxis Biobank
Status: Enrolling,
Phase
Updated: 3/20/2018
Click here to add this to my saved trials
Biliary Atresia Clinical Trial
Updated: 3/5/2018
Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia
Status: Enrolling,
Phase
Updated: 3/5/2018
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Updated: 12/31/1969
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Updated: 12/31/1969
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Updated: 12/31/1969
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Updated: 12/31/1969
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Updated: 12/31/1969
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Psychiatry / Psychology Clinical Trial
Updated: 1/30/2017
Effects of Sleep Restriction on BAT Activation in Humans
Status: Enrolling
Updated: 1/30/2017
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Kidney Transplantation Clinical Trial
Updated: 12/31/1969
Preventive Human Papilomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gestational Diabetes Clinical Trial
Updated: 12/27/2017
High Dose Cholecalciferol to Reduce the Incidence of Gestational Diabetes in High Risk Pregnant Women
Status: Enrolling,
Phase
I, II
Updated: 12/27/2017
Click here to add this to my saved trials
Breast Cancer, Respiratory Gating, Prone Clinical Trial
Updated: 1/30/2017
Prone Whole-Breast RadiationTherapy Versus Supine Whole-Breast Radiation Therapy Imaging
Status: Enrolling
Updated: 1/30/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Updated: 12/31/1969
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Updated: 12/31/1969
Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Vestibular Diseases Clinical Trial
Updated: 12/31/1969
Use of a Vibrotactile Balance Belt System for Vestibular Rehabilitation in the Pediatric Population
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Valve Stenosis Clinical Trial
Updated: 12/31/1969
Home-Based Exercise Program For Recovery After Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Valve Stenosis Clinical Trial
Updated: 12/31/1969
Home-Based Exercise Program For Recovery After Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study of Talazoparib
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study of Talazoparib
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study of Talazoparib
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study of Talazoparib
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study of Talazoparib
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study of Talazoparib
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials